Amarin Corp Plc (AMRN)

[KCSVEN]

Why do you think briefing docs will have anything that bad in it? We've seen numerous detailed reviews, we already know the things it's going to say based on those. The only question is if FDA has a real issue with MO, but it seems like MO comes down to degree of success not failure/not failure so that seems irrelevant for expanded label.

I believe shorts believe briefing docs may give them chance but odds favor briefing docs are positive, so price is MORE likely to run up after docs released.

The Adcom members will praise the study and give unanimous vote IMO and that's all that matters